These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8077867)

  • 21. [Strategies for utilization of anticoagulants in pulmonary embolism].
    Fartoukh M; Simonneau G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):949-60. PubMed ID: 10907444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antivitamins K. Mode of action, indications, principles of treatment, role of the dentist].
    Pélissier A; Alantar SA
    Actual Odontostomatol (Paris); 1990 Mar; 44(169):127-40. PubMed ID: 2143620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of anticoagulants during pregnancy].
    Lécuru F; Taurelle R; Desnos M; Ruscillo MM
    Presse Med; 1995 May; 24(19):901-4. PubMed ID: 7638132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of thromboembolic complications with adapted low-dose of antivitamins K after total hip prosthesis].
    Hernigou P; Février MJ; Kergrohen F
    Rev Chir Orthop Reparatrice Appar Mot; 1993; 79(7):577-85. PubMed ID: 8085039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombopenia induced by heparin. From physiopathology to treatment].
    Gruel Y
    Ann Med Interne (Paris); 1997; 148(2):136-41. PubMed ID: 9238438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [How to improve the monitoring of anticoagulant therapy with antivitamins K. Recommendation of the Study Group on Hemostasis and Thrombosis].
    Rev Fr Gynecol Obstet; 1987 Feb; 82(2):133-4. PubMed ID: 3563287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anticoagulant treatment of venous thromboembolic disease: optimal duration of antivitamin K therapy. Review of the literature].
    Pinède L; Ninet J; Boissel JP; Pasquier J
    Presse Med; 1994 Dec; 23(39):1817-20. PubMed ID: 7899305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute anemia induced by rupture of a luteal cyst, aggravated by the ingestion of antivitamin K].
    Thibaud D; Bellin J; Le Lorier B; Ploussard JP
    Arch Fr Pediatr; 1989 Nov; 46(9):671-3. PubMed ID: 2604528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypersensitivity and resistance to antivitamins K].
    Keréveur A; Trossaert M; Horellou MH; Conard J; Dupeyron JP; Samama M
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4):487-95. PubMed ID: 7646267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin.
    Gerotziafas GT; Dupont C; Spyropoulos AC; Hatmi M; Samama MM; Kiskinis D; Elalamy I
    Thromb Haemost; 2009 Jul; 102(1):42-8. PubMed ID: 19572066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of heparin-falithrome prophylaxis on the involution of the puerperal uterus].
    Wagner S; Roder R
    Zentralbl Gynakol; 1982; 104(23):1541-4. PubMed ID: 7164660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protein C deficiency: recurrent extensive phlebitis during the transfer from heparin to antivitamin K].
    Ninet J; Bachet P; Comte JM; Pasquier J; Follea G; Trzeciak C; Dechavanne M
    Presse Med; 1985 Jan; 14(2):108. PubMed ID: 3156326
    [No Abstract]   [Full Text] [Related]  

  • 36. [Heparin-antivitamin K transfer].
    Fiessinger JN; Aïach M
    Rev Prat; 1988 May; 38(15):944, 947-51. PubMed ID: 3393836
    [No Abstract]   [Full Text] [Related]  

  • 37. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Monitoring of anticoagulant treatment in patients with cancer].
    Mahé I; Bosquet A; Medjkane A; Bal dit Sollier C; Drouet L
    Pathol Biol (Paris); 2008 Jun; 56(4):239-44. PubMed ID: 18407438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Peripheral arterial revascularization: which antithrombotic agents?].
    Haulon S; Susen S; Koussa M; Jude B
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1278-84. PubMed ID: 11794970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.